Author

A. Parikh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Assay:proteomics· 2 Organism:human· 1 Organism:non-human primate· 1 Organism:rat· 1

Frequent Co-Authors

A. K. Singh· 2 shared S. Kumar· 2 shared V. Sharma· 2 shared A. Dara· 1 shared A. Dey· 1 shared A. Jensen-Smith· 1 shared A. S. Beaver· 1 shared A. Shete· 1 shared

Activity by Year

2021-2021 · peak 4/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

A. K. Singh

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Targeted drug release from stable and safe ultrasound-sensitive nanocarriers

M. G. Wilson, A. Parikh, A. Dara, A. S. Beaver, J. Kubanek

This study identifies stable perfluorocarbon nanocarriers and low-frequency ultrasound parameters for effective and safe targeted drug release in non-human primates.

bioRxiv · Dec 14, 2021Bioengineering

BOXR1030, an anti-GPC3 CAR with exogenous GOT2 expression, shows enhanced T cell metabolism and improved antitumor activity

T. L. Hickman, E. Choi, K. R. Whiteman, S. Muralidharan, T. Pai, T. Johnson, A. Parikh, T. Friedman, M. Gilbert, B. Shen, L. Barron, K. E. McGinness, S. A. Ettenberg, G. T. Motz, G. J. Weiss, A. Jensen-Smith

This paper evaluates BOXR1030, a CAR T cell therapy co-expressing GPC3-targeted CAR and GOT2, showing enhanced T cell metabolism and improved antitumor activity in preclinical models.

bioRxiv · Nov 17, 2021 · PreprintCancer Biology

ZRC3308 monoclonal antibody cocktail shows protective efficacy in Syrian hamsters against SARS-CoV-2 infection

P. Yadav, S. K. Mendiratta, S. Mohandas, A. K. Singh, P. Abraham, A. Shete, S. Bandhyopadhyay, S. Kumar, A. Parikh, P. Kalita, V. Sharma, H. Pandya, C. G. Patel, M. Patel, S. Soni, , M. Jain

The paper develops a monoclonal antibody cocktail (ZRC-3308) effective against multiple SARS-CoV-2 variants in Syrian hamsters.

bioRxiv · Sep 16, 2021Microbiology

Immunogenic Potential of DNA Vaccine candidate, ZyCoV-D against SARS-CoV-2 in Animal Models

A. Dey, C. Rajanathan TM, H. Chandra, H. P. Pericherla, S. Kumar, H. S. Choonia, M. Bajpai, A. K. Singh, A. Sinha, G. Saini, P. Dalal, S. Vandriwala, M. A. Raheem, R. D. Divate, N. L. Navlani, , K. Maithal

This study evaluates the immunogenic potential of the DNA vaccine ZyCoV-D against SARS-CoV-2 in animal models, showing antibody and Th-1 responses.

bioRxiv · Jan 26, 2021Immunology